Search alternatives:
greater increase » year increase (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
Showing 1 - 20 results of 6,052 for search '(( significant burden decrease ) OR ( significant ((shape decrease) OR (greater increase)) ))', query time: 0.44s Refine Results
  1. 1
    Scaling of overall health burden with yearly expenditure growth.

    Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Evolution of health burden and life expectancy under different expenditure scenarios.

    Evolution of health burden and life expectancy under different expenditure scenarios. by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    <i>Ctsz</i><sup><i>−/−</i></sup> mice have higher lung burden and earlier spleen dissemination during acute infection followed by greater chronic inflammation and mortality risk.

    <i>Ctsz</i><sup><i>−/−</i></sup> mice have higher lung burden and earlier spleen dissemination during acute infection followed by greater chronic inflammation and mortality risk.... by Rachel K. Meade (22216529)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Disease burden trends of leukemia and lymphoma analyzed by joinpoint regression analysis in mainland China.

    Disease burden trends of leukemia and lymphoma analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Cases and age-standardized rates of hematological malignancies in mainland China and their temporal trends.

    Cases and age-standardized rates of hematological malignancies in mainland China and their temporal trends. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Projections of incidence for hematological malignancies in mainland China.

    Projections of incidence for hematological malignancies in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for lymphoma, multiple myeloma, and other hematological neoplasms in mainland China.

    Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for lymphoma, multiple myeloma, and other hematological neoplasms in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Disease burden trends of multiple myeloma and other hematological neoplasms analyzed by joinpoint regression analysis in mainland China.

    Disease burden trends of multiple myeloma and other hematological neoplasms analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Cases and age-standardized rates of hematological malignancies in Taiwan and their temporal trends.

    Cases and age-standardized rates of hematological malignancies in Taiwan and their temporal trends. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    The raw data used in this study.

    The raw data used in this study. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for leukemia in mainland China.

    Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for leukemia in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Projections of mortality for hematological malignancies in mainland China.

    Projections of mortality for hematological malignancies in mainland China. by Yu Fu (16582)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Significantly Enriched Pathways.

    Significantly Enriched Pathways. by Jiyong Zhang (2498740)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    (A) Shape of the osteotomies during the 3-step MIPS drilling procedure.

    (A) Shape of the osteotomies during the 3-step MIPS drilling procedure. by Marsel Ganeyev (21453399)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Nodes with eccentricity values greater than 7.

    Nodes with eccentricity values greater than 7. by Xizhen Xu (476895)

    Published 2025
    “…<div><p>Prefabricated buildings face greater and different prefabricated components throughout their entire lifecycle, leading to a significant increase in management difficulty. …”
    Save to List
    Saved in:
  16. 16
    The combination of 3-MA and CDDP significantly increased CDDP-induced cell death.

    The combination of 3-MA and CDDP significantly increased CDDP-induced cell death. by Jie Zhou (28945)

    Published 2025
    Save to List
    Saved in:
  17. 17
    Capabilities expansion scenarios considered. <i><i>g</i></i><sub>GDP</sub> and <i><i>g</i></i><sub>fHE</sub> refer to the growth rate of annual GDP (in constant 2015 US$) and growth rate of fraction of GDP allocated to health (<i><i>f</i></i><sub>HE</sub>) assumed, leading to a yearly expenditure growth per scenario of [(1 + <i><i>g</i></i><sub>GDP</sub>) × (1 + <i><i>g</i></i><sub>fHE</sub>) − 1]. The normalised health expenditure (NHE) associated with each scenario (defined in

    Capabilities expansion scenarios considered. <i><i>g</i></i><sub>GDP</sub> and <i><i>g</i></i><sub>fHE</sub> refer to the growth rate of annual GDP (in constant 2015 US$) and growt... by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Impact on different areas of health.

    Impact on different areas of health. by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Splenocytes from Tcj2 mRNA LNP—Immunized mice decrease <i>T</i>. <i>cruzi</i> infection <i>in vitro</i>.

    Splenocytes from Tcj2 mRNA LNP—Immunized mice decrease <i>T</i>. <i>cruzi</i> infection <i>in vitro</i>. by Leroy Versteeg (4248760)

    Published 2024
    Save to List
    Saved in:
  20. 20
    Nodes with betweenness centrality values greater than 60.

    Nodes with betweenness centrality values greater than 60. by Xizhen Xu (476895)

    Published 2025
    Save to List
    Saved in:

Search Tools: